Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-12 04:31:30 EDT

Explore

PostsPeople
LatestRanked
@thelancetendo.bsky.socialOct 2, 2026, 6:19 AM

S Alice Longa & Cate Speake comment on:
#IL-2 and immunoregulatory therapies in newly diagnosed type 1 #diabetes thelancet.com/journals/lan...
#T1D
#EASD2026

#MedSky #EndoSky

@thelancetendo.bsky.socialOct 2, 2026, 6:19 AM

New—Efficacy and safety of low-dose #IL-2 in people with newly diagnosed type 1 #diabetes (DIABIL-2): a double-blind, multicentre, randomised, placebo-controlled, phase 2b trial thelancet.com/journals/lan...
#T1D
#EASD2026

#MedSky #EndoSky

@baladocritique.bsky.socialOct 1, 2026, 11:01 AM

“Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults.”
Publié ce jour dans le @nejm.org.
#MedSky #EndoSky
www.nejm.org/doi/full/10....

@thelancetendo.bsky.socialOct 1, 2026, 10:41 AM

New—Diabetes and the role of primary care: a global perspective thelancet.com/journals/lan...
#diabetes
#EASD2026

#MedSky #EndoSky

@thelancetendo.bsky.socialOct 1, 2026, 9:33 AM

#AI has substantial potential in screening, classifying, predicting, and preventing #diabetes. In primary care, AI-driven solutions can provide personalised treatment plans and empower self-management www.thelancet.com/journals/lan...
#T1D #T2D
#EASD2026

#MedSky #EndoSky

@thelancetendo.bsky.socialOct 1, 2026, 7:44 AM

Published in @thelancet.com

#Retatrutide in adults with #obesity and type 2 #diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial www.thelancet.com/journals/lan...
#T2D
#EASD2026

#MedSky #EndoSky

@thelancetendo.bsky.socialOct 1, 2026, 7:12 AM

Shukri F Mohameda & Andre Pascal Kengne comment on:
What #Mauritius teaches us about #diabetes surveillance thelancet.com/journals/lan...
#T2D #OGTT
#FREE to read w/reg (also FREE)
#EASD2026

#MedSky #EndoSky

@thelancetendo.bsky.socialOct 1, 2026, 7:12 AM

New—Trends in prevalence of type 2 #diabetes and intermediate #hyperglycaemia in #Mauritius from 1987 to 2021 based on results from the oral glucose tolerance test: a repeated cross-sectional study thelancet.com/journals/lan...
#T2D #OGTT
#FREE to read w/reg (also FREE)
#EASD2026

#MedSky #EndoSky

@thelancetendo.bsky.socialOct 1, 2026, 7:04 AM

New Editorial:
Safeguarding paediatric metabolic health www.thelancet.com/journals/lan...
#obesity
#FREE to read

#MedSky #EndoSky

@driramhussain.bsky.socialSep 30, 2026, 9:13 PM

The ATA has discouraged the use of T3 for depression. The risks of a suppressed TSH are well known.

But the suggestion to use a brain-selective T3 analog in chronically depressed patients? That may have some merit.

Thyroid, August 2026

#EndoSky

@thelancetendo.bsky.socialSep 30, 2026, 6:27 AM

Sten Madsbad & Jens J Holst comment on:
Petrelintide and the evolving role of amylin agonism in obesity thelancet.com/journals/lan...
#obesity
#EASD2026

#MedSky #EndoSky

@thelancetendo.bsky.socialSep 30, 2026, 6:27 AM

New—Petrelintide, a human amylin analogue for the treatment of obesity (ZUPREME 1): a randomised, double-blind, placebo-controlled, phase 2 trial thelancet.com/journals/lan...
#obesity
#EASD2026

#MedSky #EndoSky

(A) Estimated mean change in bodyweight by treatment week (efficacy estimand). (B) Least squares mean change in bodyweight from baseline to week 42 (efficacy estimand). (C) Observed mean change in bodyweight by treatment week (treatment policy estimand). (D) Least squares mean change in bodyweight (%) from baseline to week 42 (treatment policy estimand). *p<0·0001 for difference versus placebo. †Treatment policy estimates at week 42.
@thelancetendo.bsky.socialSep 29, 2026, 1:03 PM

New—Disease modification outcomes in type 2 #diabetes: a modified Delphi thelancet.com/journals/lan...
#T2D
#EASD2026

#MedSky #EndoSky

@thelancetendo.bsky.socialSep 29, 2026, 9:45 AM

Also read the original TimeCapsule article:
A quarter-century of progress: innovations in lipid medicine that transformed cardiovascular prevention thelancet.com/journals/lan...
#LDL #cholesterol #ASCVD #statins #PCSK9 inhibitors

#MedSky #EndoSky #CardioSky

@thelancetendo.bsky.socialSep 29, 2026, 9:45 AM

25 Years of Lipid Medicine youtube.com/watch?v=atCH...
#LDL #cholesterol #ASCVD
#statins #PCSK9 inhibitors

#MedSky #EndoSky #CardioSky

@thelancetendo.bsky.socialSep 28, 2026, 2:16 PM

#Semaglutide was effective in decreasing #CKD progression regardless of the administration route or indication (type 2 #diabetes or #obesity), adding to the evidence provided by FLOW in people with type 2 diabetes & CKD www.thelancet.com/journals/lan...
#T2D

#MedSky #EndoSky #RenalSky #CardioSky

@thelancetendo.bsky.socialSep 28, 2026, 8:42 AM

Published in @ebiomedicine.bsky.social

Metabolomic profiling of ultra-processed food consumption and #cardiovascular risk in Spanish preschool children: a cross-sectional study www.thelancet.com/journals/ebi...
#UPFs #CVD
#OpenAccess

#MedSky #EndoSky #CardioSky

@thelancetendo.bsky.socialSep 28, 2026, 8:40 AM

Published in @lancetrh-europe.bsky.social

Prenatal high-dose vitamin D supplementation and offspring bone mineral content and density at age 13 years: a secondary analysis of a randomised clinical trial www.thelancet.com/journals/lan...
#VitaminD #BoneHealth
#OpenAccess

#MedSky #EndoSky

@thelancetendo.bsky.socialSep 28, 2026, 8:37 AM

Published in @eclinicalmed.bsky.social

Overnight metyrapone in mild autonomous cortisol secretion: a single-centre, single-arm, phase 2 trial www.thelancet.com/journals/ecl...
#OpenAccess

#MedSky #EndoSky

@springermedicine.comSep 26, 2026, 10:54 AM

Examine the pathophysiology, clinical presentation, diagnostic approach, and neuroimaging features for infiltrative and inflammatory disorders involving the pituitary gland, with strategies to aid recognition and management.

👉️ buff.ly/Ql9BBHL

#EndoSky

Load more